Gerardo Ferbeyre, a research member at the Institute, and Sebastian Igelmann, a doctoral student in his laboratory and first author of the study, have made a discovery that opens a new avenue for potential cancer therapies. The two scientists published a study in Molecular Cell showing that an enzyme complex called HTC (hydride transfer complex) can inhibit cell aging.
When cells age, a state called “cellular senescence” occurs and cells stop dividing. HTC, composed of three enzymes, may be a potential target for stopping the growth of cancer cells in certain types of cancer, including prostate cancer.
Other news
![Preventing cells from aging: the discovery of Gerardo Ferbeyre and Sebastian Igelmann](https://www.icm.qc.ca/wp-content/uploads/2020/11/istock-1044233084-1600x1600.jpg)
Subscribe to our newsletter
Thank you, we have received your registration
Sorry, an error occurred
![](https://www.icm.qc.ca/wp-content/themes/icm/assets/img/ajax-loader.gif)